Why the study?
Does cardiomyocyte-specific deletion of Cathepsin K prevent doxorubicin-induced cardiotoxicity in mice?
Population
Four-month-old control and cardiomyocyte-specific Cathepsin K knockout mice
Comparison
Intraperitoneal injections of doxorubicin vs Vehicle injection
Design
Preclinical
Follow-up
1 week
Authors
Loading...
Cardiomyocyte Cathepsin K deletion attenuates doxorubicin cardiotoxicity in mice; hypothesis-generating and requires clinical validation before any therapeutic consideration.
Does cardiomyocyte-specific deletion of Cathepsin K prevent doxorubicin-induced cardiotoxicity in mice?
Cardiomyocyte-specific deletion of Cathepsin K protects against doxorubicin-induced cardiotoxicity by attenuating apoptosis, inflammation, and metabolic disturbances, suggesting Cathepsin K as a potential therapeutic target.
Guo et al. (2018) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: